Piper methysticum tablet for moderate to severe depression
Part of Mental health clinical trials.
This study tests a new tablet made from a plant compound for people with moderate to severe depression. It aims to see if the treatment is safe and helps improve mood, and may be an option for those who have not tried many other antidepressants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with depression (single or recurring) and, if it's a first episode, it has lasted at least 3 months.
- Your depression is rated as moderate to severe based on a standard questionnaire.
- You have not tried two or more different antidepressants in this current episode without benefit.
- You are generally healthy, without serious heart, liver, kidney, or other major medical conditions.
- You are not pregnant or planning pregnancy during the study and agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
This trial tests a single dose of an investigational drug (CYB003) in people with depression and anxiety who haven't gotten enough help from their current antidepressant. You would take a psilocybin-like medication and be monitored for how it affects your mood and anxiety.
This trial tests whether a medicine called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat depression. You would have a few sessions with a therapist and receive the medicine in a safe setting, which might improve your mood.
This study tests whether combining psilocybin (a psychedelic substance) with pimavanserin (a medication that may help reduce side effects) works better than psilocybin alone for treating major depressive disorder. It may help people who have not responded well to other treatments.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.